Price Alert

Alzamend Neuro Inc. (ALZN)

NASDAQ: ALZN · Real-Time Price · USD

2.40

0.02 (1.05%)

At close: Aug 18, 2025, 10:39 AM

Alzamend Neuro Balance Sheet Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q1 2021
Period Ending	Jan 31, 2025	Oct 31, 2024	Jul 31, 2024	Apr 30, 2024	Jan 31, 2024	Oct 31, 2023	Jul 31, 2023	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021	Jul 31, 2020
Cash & Equivalents	3.36M	4.09M	1.19M	376.05K	282.87K	200.08K	1.7M	5.14M	7.38M	9.18M	11.53M	14.06M	11.79M	13.57M	15.62M	1.93M	40.74K	-90.28K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	180.57K
Long-Term Investments	n/a	n/a	n/a	n/a	70K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	0.00	-0.00	0.00	n/a	n/a	n/a	n/a	n/a	-90.28K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.41K	n/a	n/a	16.21K	16.21K	16.21K	16.21K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	3.95M	4.77M	1.42M	455.24K	593.61K	781.88K	2.41M	5.84M	8.42M	10.33M	12.11M	14.41M	12.43M	14.5M	16.82M	2.91M	802.01K	90.28K
Property-Plant & Equipment	228.29K	240.98K	253.66K	176.35K	189.03K	201.72K	214.4K	79.84K	85.17K	90.49K	95.81K	102.91K	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	228.29K	240.98K	253.66K	176.35K	259.03K	201.72K	214.4K	79.84K	85.17K	90.49K	95.81K	102.91K	n/a	n/a	n/a	n/a	n/a	-90.28K
Total Assets	4.18M	5.01M	1.67M	631.59K	852.64K	983.6K	2.63M	5.92M	8.5M	10.42M	12.21M	14.52M	12.43M	14.5M	16.82M	2.91M	802.01K	n/a
Account Payables	725.85K	1.25M	2.88M	2.93M	3.83M	3.67K	2.74M	2.87M	2.64M	648.12K	1.03M	1.16M	464.89K	1.13M	1.07M	503.59K	877.02K	n/a
Deferred Revenue	n/a	n/a	n/a	-2.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	300.71K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	344.89K	340.1K	335.3K	1.22M	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	989.33K	n/a	n/a	2.08K	2.18K	n/a	60.75K	n/a	n/a
Total Current Liabilities	725.85K	1.25M	2.88M	3.23M	3.83M	3.67M	2.74M	2.87M	2.64M	1.64M	1.03M	1.16M	466.98K	1.48M	1.47M	899.64K	2.1M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	1.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	1.22M	n/a	n/a	n/a	n/a	648.12K	1.03M	1.16M	464.89K	1.47M	n/a	n/a	n/a	n/a
Total Liabilities	725.85K	1.25M	2.88M	3.23M	5.05M	3.67M	2.74M	2.87M	2.64M	1.64M	1.03M	1.16M	466.98K	1.48M	1.47M	899.64K	2.1M	n/a
Total Debt	n/a	n/a	n/a	300.71K	477.74K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	344.89K	340.1K	335.3K	356.59K	n/a
Common Stock	580.00	523.00	86.00	69.00	662.00	647.00	9.69K	9.69K	9.64K	9.55K	9.55K	9.55K	9.01K	8.88K	8.69K	6.74K	6.48K	n/a
Retained Earnings	-57.4M	-56.41M	-54.99M	-54.02M	-53.17M	-50.51M	-47.6M	-44.07M	-40.77M	-35.34M	-32.23M	-29.19M	-25.33M	-22.75M	-19.15M	-16.83M	-15.58M	n/a
Comprehensive Income	n/a	n/a	n/a	0.00	-477.74K	-14.88M	-14.88M	-14.88M	n/a	-14.88M	-14.88M	-14.88M	-14.88M	-14.88M	-14.88M	-14.88M	-14.88M	821.63K
Shareholders Equity	3.45M	3.75M	-1.21M	-2.59M	-4.19M	-2.68M	-112.88K	3.05M	5.86M	8.79M	11.18M	13.35M	11.96M	13.03M	15.34M	2.01M	-1.3M	821.71K
Total Investments	n/a	n/a	n/a	n/a	70K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	180.57K